Trump tariffs will challenge the big pharmaceuticals. Here are well positioned actions
Long Data Commercial Agreements have greatly protected the pharmaceutical industry of tariffs, but the objective of President Donald Trump to…
Long Data Commercial Agreements have greatly protected the pharmaceutical industry of tariffs, but the objective of President Donald Trump to…
A sign is outside an ABBVie installation in Cambridge, Massachusetts. Brian Snyder | Reuters A version of this article appeared…
The trends may be turning in favor of biotech stocks in 2025 after several years of poor performance, but it…
Shortly after the bell rings, we will buy 300 shares of Bristol Myers Squibb at approximately $56.50. Following the deal,…
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Activists protest prescription drug prices in front of the U.S. Department of Health and Human Services building in Washington, DC,…
President Joe Biden speaks during an event at the National Institutes of Health in Bethesda, Maryland, Dec. 14, 2023. Chris…
This year’s presidential election is already prompting a flurry of health care stocks. Historically, shifts in political control have created…
Humira, the injectable treatment for rheumatoid arthritis, appears at a pharmacy in Cambridge, Massachusetts. JB Reed | Bloomberg | fake…
As debate continues over when the Federal Reserve might begin cutting interest rates, biotech industry analysts argue that the case…